Literature DB >> 21680517

E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.

Rosita Accardi1, Rosa Rubino, Mariafrancesca Scalise, Tarik Gheit, Naveed Shahzad, Miranda Thomas, Lawrence Banks, Cesare Indiveri, Bakary S Sylla, Rosa A Cardone, Stephan J Reshkin, Massimo Tommasino.   

Abstract

Previous studies have shown that the PDZ-binding motif of the E6 oncoprotein from the mucosal high-risk (HR) human papillomavirus (HPV) types plays a key role in HPV-mediated cellular transformation in in vitro and in vivo experimental models. HR HPV E6 oncoproteins have the ability to efficiently degrade members of the PDZ motif-containing membrane-associated guanylate kinase (MAGUK) family; however, it is possible that other PDZ proteins are also targeted by E6. Here, we describe a novel interaction of HPV type 16 (HPV16) E6 with a PDZ protein, Na(+)/H(+) exchange regulatory factor 1 (NHERF-1), which is involved in a number of cellular processes, including signaling and transformation. HPV16 E6 associates with and promotes the degradation of NHERF-1, and this property is dependent on the C-terminal PDZ-binding motif of E6. Interestingly, HPV16 E7, via the activation of the cyclin-dependent kinase complexes, promoted the accumulation of a phosphorylated form of NHERF-1, which is preferentially targeted by E6. Thus, both oncoproteins appear to cooperate in targeting NHERF-1. Notably, HPV18 E6 is not able to induce NHERF-1 degradation, indicating that this property is not shared with E6 from all HR HPV types. Downregulation of NHERF-1 protein levels was also observed in HPV16-positive cervical cancer-derived cell lines, such as SiHa and CaSki, as well as HPV16-positive cervical intraepithelial neoplasia (CIN). Finally, our data show that HPV16-mediated NHERF-1 degradation correlates with the activation of the phosphatidylinositol-3'-OH kinase (PI3K)/AKT signaling pathway, which is known to play a key role in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680517      PMCID: PMC3147992          DOI: 10.1128/JVI.00114-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

Review 2.  PI(3)king apart PTEN's role in cancer.

Authors:  Siyuan Zhang; Dihua Yu
Journal:  Clin Cancer Res       Date:  2010-07-08       Impact factor: 12.531

3.  HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.

Authors:  M Thomas; B Glaunsinger; D Pim; R Javier; L Banks
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

Review 4.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

5.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

7.  Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling.

Authors:  Matthew J Mahon; Mark Donowitz; C Chris Yun; Gino V Segre
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

8.  The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.

Authors:  Marie L Nguyen; Minh M Nguyen; Denis Lee; Anne E Griep; Paul F Lambert
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.

Authors:  Sandra Caldeira; Ingeborg Zehbe; Rosita Accardi; Ilaria Malanchi; Wen Dong; Marianna Giarrè; Ethel-Michele de Villiers; Raffaele Filotico; Petra Boukamp; Massimo Tommasino
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.

Authors:  Richard A Watson; Miranda Thomas; Lawrence Banks; Sally Roberts
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

View more
  26 in total

1.  Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.

Authors:  Daliborka Lazić; Martin Hufbauer; Paola Zigrino; Stephanie Buchholz; Siamaque Kazem; Mariet C W Feltkamp; Cornelia Mauch; Gertrud Steger; Herbert Pfister; Baki Akgül
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 2.  New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Authors:  Adrienne M Bushau-Sprinkle; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

Review 3.  Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.

Authors:  J Vaquero; T H Nguyen Ho-Bouldoires; A Clapéron; L Fouassier
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.

Authors:  Nathaniel Edward Bennett Saidu; Vedrana Filić; Miranda Thomas; Vanessa Sarabia-Vega; Anamaria Đukić; Frane Miljković; Lawrence Banks; Vjekoslav Tomaić
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.

Authors:  Moonju Choi; Sungjin Lee; Taekyu Choi; Choongho Lee
Journal:  Virus Genes       Date:  2013-11-29       Impact factor: 2.332

Review 6.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

7.  Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.

Authors:  Sydney Webb Strickland; Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2018-01-12       Impact factor: 3.616

Review 8.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

9.  NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.

Authors:  Rosa Angela Cardone; Maria Raffaella Greco; Mattia Capulli; Edward J Weinman; Giovanni Busco; Antonia Bellizzi; Valeria Casavola; Ester Antelmi; Barbara Ambruosi; Maria Elena Dell'Aquila; Angelo Paradiso; Anna Teti; Nadia Rucci; Stephan Joel Reshkin
Journal:  Mol Biol Cell       Date:  2012-04-11       Impact factor: 4.138

Review 10.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.